- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – The Evolving Psychopharmacology of Major Depressive Disorder

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – The Evolving Psychopharmacology of Major Depressive Disorder
This is a Virtual Event for PsychU members in Georgia.
In this presentation, the objectives are to:
- Provide a brief overview of depression prevalence and current standard treatments
- Review the monoamine hypothesis of depression
- Discuss alternative hypotheses of depression
- Highlight potential new therapeutic intervention targets
Featuring
-
Samuel Shillcutt, PhD
Professor Emeritus, Mercer University School of Medicine, Department of Psychiatry
-
Walter Lawhorn, PharmD (OPDC)
Regional Medical Lead
Speaker Samuel Shillcutt, Phd is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc. Speaker Walter Lawhorn, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.